Clinical Trial Update: Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immune response of an H5N1 avian influenza vaccine in healthy adults. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H5N1 Avian Influenza Vaccine (avian influenza vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza, Virus Diseases | Phase 1 | Status: COMPLETED